Health Canada issued a public advisory after a drug used to treat high blood pressure and chest pain has been recalled ...

Wildfire smoke continues to hang over much of Manitoba, leading Environment Canada and Manitoba Health to issue an air ...

U.S. telehealth upstart Hims & Hers Health, Inc. is planning to enter the Canadian market with an eye to selling generic ...

With measles outbreaks, avian influenza and syphilis and HIV on the rise, Canada needs to strengthen its disease surveillance ...

Florida’s importation program hasn’t brought in a single Canadian drug. It’s not cost-effective and it could be dangerous.

Until recently, the UN was on track to meet its target of ending AIDS as a public health threat by 2030. But with the U.S.

Novo Nordisk will lose its patent protection on its branded semaglutide drugs Ozempic and Wegovy in Canada after not paying a ...

U.S. telehealth platform looks to take advantage of Ozempic patent expiring in January, while four manufacturers filed for ...

With a fresh wave of patriotic calls for Canada to scale its domestic tech sector, industry players say there are ...

Hims & Hers Health, Inc. (NYSE: HIMS) the leading digital health and wellness platform, today announced its plans to bring ...

Health Canada has issued a health product recall notice for a certain lot of Dr. Nutrition 360 Magnesium 200 mg capsules due to an incorrect non-medicinal ingredient.

Hims & Hers Health plans to expand into Canada, timing it with the new availability of the generic weight loss medication on the market for the first time.